User:ChrisMisu/Cost of drug development/Bibliography

User:ChrisMisu/Cost of drug development/Bibliography

You will be compiling your bibliography and creating an outline of the changes you will make in this sandbox.

Outline of proposed changes
This is a scientific journal discusses both the dynamics between drug approval and stock prices and the R&D impact on company's financial performance.


 * Drug Approval and Stock Prices: The study's findings suggest that FDA approvals and other R&D-related news significantly impact pharmaceutical companies' stock prices, though not always as drastically as might be expected. This could inform an understanding of how drug price negotiations and patent dynamics affect Pfizer's financial performance.


 * R&D Impact on Financial Performance: The relationship between R&D milestones (like clinical trial outcomes or regulatory approvals) and stock price volatility highlights the financial implications of Pfizer's R&D decisions and outcomes.